Skip to content
Abierto

Award notice

Medication Discovery Using Rat Models of Relapse

75N95024C00020

National Institutes of Health, National Institutes of Health Nida. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

Awarded

Virginia Commonwealth University

$8,795,372.00 on the award notice, July 9, 2024, contract 75N95024C00020

Description

As published on SAM.gov.

Medication Discovery Using Rat Models of Relapse On February 16, 2024; in response to the requirements of Request for Proposal 75N95024R00011, the National Institute on Drug Abuse (NIDA) awarded one (1) cost-plus fixed fee contract for a period of performance of five (5) years. The total contract and obligated amount shall not exceed $8,795,372.00.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
MLQFL4JSSAA9
CAGE
46050
Vendor location
Richmond, VA
Contract
75N95024C00020, definitive contract
Obligated
$3,014,207.00, potential $7,845,352
Actions
6 between July 9, 2024 and August 10, 2026
Competition
Full and Open Competition, 3 offers received
Set-aside reported
No Set Aside Used.
Described as
Medication Discovery Using Rat Models of Relapse. Period of Performance: 7/10/2024-7/9/2025. N01DA-24-8949
Match
award number 75N95024C00020 equals the contract number; same awarding office 75N950 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 9, 2024

    Award notice, originally solicitation

    Awarded to VIRGINIA COMMONWEALTH UNIVERSITY Richmond for $8,795,372. SAM.gov, notice dea158b5a0864cb98d01d017b23c70ae

  2. July 10, 2024

    Award notice

    Awarded to VIRGINIA COMMONWEALTH UNIVERSITY Richmond for $8,795,372. SAM.gov, notice 120ccf82e7764e83ad14c0338dbd9adf

Points of contact